|
US6635632B1
(en)
|
1996-12-23 |
2003-10-21 |
Athena Neurosciences, Inc. |
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
WO1999066934A1
(en)
*
|
1998-06-22 |
1999-12-29 |
Elan Pharmaceuticals, Inc. |
CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
|
|
AU4707999A
(en)
*
|
1998-06-22 |
2000-01-10 |
Elan Pharmaceuticals, Inc. |
Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
|
|
US6774125B2
(en)
|
1998-06-22 |
2004-08-10 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
JP2002518482A
(ja)
*
|
1998-06-22 |
2002-06-25 |
エラン ファーマシューティカルズ,インコーポレイテッド |
β−アミロイドペプチド放出および/またはその合成を阻害する化合物
|
|
US6552013B1
(en)
|
1998-06-22 |
2003-04-22 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
US6958330B1
(en)
|
1998-06-22 |
2005-10-25 |
Elan Pharmaceuticals, Inc. |
Polycyclic α-amino-ε-caprolactams and related compounds
|
|
US6509331B1
(en)
|
1998-06-22 |
2003-01-21 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
NZ525513A
(en)
|
1998-08-07 |
2004-09-24 |
Pont Pharmaceuticals Du |
Succinoylamino lactams as inhibitors of Abeta protein production
|
|
HRP990246A2
(en)
|
1998-08-07 |
2000-06-30 |
Du Pont Pharm Co |
Succinoylamino benzodiazepines as inhibitors of a beta protein production
|
|
AU6278099A
(en)
|
1998-09-30 |
2000-04-17 |
Elan Pharmaceuticals, Inc. |
Biological reagents and methods for determining the mechanism in the generation of beta-amyloid peptide
|
|
CN1636011A
(zh)
|
1998-12-24 |
2005-07-06 |
杜邦药品公司 |
作为Aβ蛋白产生抑制剂的琥珀酰氨基苯并二氮杂䓬
|
|
HK1045157A1
(zh)
|
1999-01-22 |
2002-11-15 |
依兰制药公司 |
抑制vla-4介导的白细胞粘着的化合物
|
|
US6503902B2
(en)
|
1999-09-13 |
2003-01-07 |
Bristol-Myers Squibb Pharma Company |
Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production
|
|
US6960576B2
(en)
|
1999-09-13 |
2005-11-01 |
Bristol-Myers Squibb Pharma Company |
Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
|
|
EP1222176A1
(en)
|
1999-10-08 |
2002-07-17 |
Bristol-Myers Squibb Pharma Company |
AMINO LACTAM SULFONAMIDES AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION
|
|
BR0016652A
(pt)
|
1999-12-23 |
2002-11-19 |
Neurochem Inc |
Métodos para inibir angiopatia amilóide cerebral, para tratar um estado de doença caracterizado por angiopatia amilóide cerebral em um indivìduo, e para diagnosticar angiopatia amilóide cerebral em um indivìduo
|
|
EP1261610A2
(en)
|
2000-02-17 |
2002-12-04 |
Bristol-Myers Squibb Pharma Company |
Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production
|
|
EP1268434A1
(en)
|
2000-04-03 |
2003-01-02 |
Bristol-Myers Squibb Pharma Company |
Cyclic lactams as inhibitors of a-beta protein production
|
|
MXPA02009755A
(es)
|
2000-04-03 |
2003-03-27 |
Bristol Myers Squibb Pharma Co |
Lactamas ciclicas como inhibidores de la produccion de proteina a-beta.
|
|
WO2001077086A1
(en)
|
2000-04-11 |
2001-10-18 |
Dupont Pharmaceuticals Company |
SUBSTITUTED LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION
|
|
WO2001087354A2
(en)
|
2000-05-17 |
2001-11-22 |
Bristol-Myers Squibb Pharma Company |
Use of small molecule radioligands for diagnostic imaging
|
|
IL147629A0
(en)
|
2000-06-01 |
2002-08-14 |
Bristol Myers Squibb Pharma Co |
LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
|
|
US6432944B1
(en)
|
2000-07-06 |
2002-08-13 |
Bristol-Myers Squibb Company |
Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives
|
|
ZA200304059B
(en)
*
|
2000-12-28 |
2004-07-06 |
Daiichi Seiyaku Co |
VLA-4 inhibitors.
|
|
CA2430978C
(en)
*
|
2000-12-28 |
2012-05-15 |
Daiichi Pharmaceutical Co., Ltd. |
Vla-4 inhibitors
|
|
MXPA04005451A
(es)
*
|
2001-12-04 |
2005-01-14 |
Elan Pharm Inc |
Isoesteres peptidicos que contienen un heterociclo util en el tratamiento de enfermedad de alzheimer.
|
|
TWI281470B
(en)
|
2002-05-24 |
2007-05-21 |
Elan Pharm Inc |
Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
|
|
TW200307671A
(en)
|
2002-05-24 |
2003-12-16 |
Elan Pharm Inc |
Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
|
|
AU2003247758A1
(en)
|
2002-06-27 |
2004-01-19 |
Elan Pharmaceuticals, Inc. |
Methods for treating alzheimer's disease using hydroxyethylene compounds containing a heterocyclic amide bond isostere
|
|
FR2842523A1
(fr)
*
|
2002-07-17 |
2004-01-23 |
Sanofi Synthelabo |
Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
|
|
JP4676884B2
(ja)
|
2003-07-24 |
2011-04-27 |
第一三共株式会社 |
シクロヘキサンカルボン酸類
|
|
ZA200803016B
(en)
|
2005-09-29 |
2009-10-28 |
Elan Pharmaceuticals Inc Wyeth |
Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
ATE493405T1
(de)
|
2005-09-29 |
2011-01-15 |
Elan Pharm Inc |
Pyrimidinylamidverbindungen, die die durch vla-4 vermittelte leukozytenadhäsion inhibieren
|
|
EA017110B1
(ru)
|
2006-02-27 |
2012-09-28 |
Элан Фамэсьютикэлс, Инк. |
ПИРИМИДИНИЛСУЛЬФОНАМИДНЫЕ СОЕДИНЕНИЯ (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ ПИРИМИДИНИЛСУЛЬФОНАМИДНЫХ СОЕДИНЕНИЙ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, ОПОСРЕДОВАННОГО ИНТЕГРИНОМ α4, СПОСОБ СНИЖЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ВОСПАЛИТЕЛЬНОГО КОМПОНЕНТА ЗАБОЛЕВАНИЯ ИЛИ АУТОИММУННОГО ОТВЕТА
|